Skip to main content

Table 1 Overview of risk information communicated in the intervention

From: Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling

Population risk:

Lifetime breast cancer risk: 10 out of 100 for breast cancer patients

Breast cancer risk due to hereditary causes: 5 to 10 out of 100

Carriers of BRCA1/BRCA2 mutation:

Lifetime breast cancer risk: 60 to 80 out of 100

Risk passing a BRCA1/BRCA2 mutation to children: 50 out of 100

Women with the same family history:

Lifetime breast cancer risk:

ā€ƒā€ƒā€ƒ- 11ā€“20 out of 100 for women in a low risk category

ā€ƒā€ƒā€ƒ- 20ā€“30 out of 100 for women in a moderate risk category

ā€ƒā€ƒā€ƒ- 30ā€“40 out of 100 for women in a high risk category

Risk having a BRCA1/BRCA2 mutation: less than 10 out of 100 and specified if more than 10 out of 100